drugset / Trial / NCT00376311
Effects of Oral Salmon Calcitonin in Human Osteoarthritis
RandomizedParallel-groupDouble-blindTreatment
Summary
To assess the safety, tolerability and clinical efficacy of oral salmon calcitonin in patients suffering from osteoarthritis
Timeline
- Start
- 2002-09
- Primary completion
- —
- Completion
- 2004-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | salmon calcitonin | Unknown | 0.5 mg | Oral |
| Subject | salmon calcitonin | Unknown | 1 mg | Oral |